IMMUNOTECH-B (06978) has announced that all conditions under the subscription agreement have been fulfilled or waived, as applicable. The company has issued new convertible bonds with a total principal amount of RMB 270 million and notes with a principal amount of RMB 30 million to investors in accordance with their respective terms and conditions. As of the announcement date, the proceeds from the subscription will be used exclusively to fully and finally settle the principal amount of the 2023 convertible bonds, which are due on February 20, 2026.